Powl Brian T. — SEC Form 4 filings
SEC reporting owner CIK 1934232. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2025-01-06 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 40,459 shares, $410,347 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 10,000 shares @ $11.00 ($110,000) in Kura Oncology, Inc., filed 2026-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | Chief Commercial Officer | 9 | — | 8 legs · 40,459 sh · $410,347 | 6 |
Form 4 filings — Powl Brian T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 4,345 @ $11.89 | EDGAR |
| 2026-05-22 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 10,000 @ $11 | EDGAR |
| 2026-05-20 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 339 @ $9.21 | EDGAR |
| 2026-01-27 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 4,842 @ $8.46 · Sale (S): 1,572 @ $8.46 | EDGAR |
| 2026-01-06 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 48,900 @ $0 · Sale (S): 8,887 @ $11.18 | EDGAR |
| 2025-09-29 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 48,900 @ $0 · Sale (S): 8,891 @ $8.94 | EDGAR |
| 2025-01-28 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 1,583 @ $7.87 | EDGAR |
| 2025-01-06 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 46,250 @ $0 · Grant/award (A): 92,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1934232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →